Navigation Links
Genomics of Cardiovascular Disease: Current Clinical Applications
Date:6/5/2008

KEYNOTE SPEAKER - Kari Stefansson, MD, DR. MED, CEO DeCODE Genetics

WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The following media advisory was issued today by The Cheney Cardiovascular Institute:

Date: Thursday, June 12, 2008

Location: The George Washington University Hospital Auditorium

900 23rd Street, NW

Time: Noon - 2:50pm

Noon - 1:00pm Presentation by Dr. Kari Stefansson

Dr. Stefansson is CEO and co-founder of deCODE genetics and a former professor of neurology, neuropathology, and neuroscience at Harvard University.

The deCODE group has identified unique genomic markers for atherosclerosis, atrial fibrillation, and type II diabetes mellitus. As one of the world's leading experts on genomics, Dr. Stefansson will discuss the current clinical applications of cardiovascular personalized medicine. Key to understanding the potential of genomics, Dr. Stefansson will define single nucleotide polymorphisms (SNPs) and their role in genetic diseases. His talk will highlight the breakthroughs in cardiovascular genomics for both clinical cardiologists as well as researchers.

1:15 - 2:50pm Luncheon panel discussion -

Moderated by Timothy McCaffrey, PhD

Stephen B. Liggett, MD

Professor of Medicine and Physiology

Director, Cardiopulmonary Genomics

University of Maryland School of Medicine

Timothy McCaffrey, PhD

Professor of Biochemistry and Director, McCormick Genomics Center, The George Washington University School of Medicine

Gualberto Ruano, MD, PhD

President and CEO, Genomas, Inc.

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006 by a generous charitable contribution from Vice President Richard Cheney and his wife Lynne.

The mission of The Richard B. and Lynne V. Cheney Cardiovascular Institute is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health policy experts and community leaders. For more information, please visit http://www.cheneycardioinstitute.com.


'/>"/>
SOURCE The Cheney Cardiovascular Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
2. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
3. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
4. NIH announces new initiative in epigenomics
5. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
6. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
7. NeoGenomics Announces Results for the 3rd Quarter 2007
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that ... dermaka cream can be incorporated into the post-surgical treatment plans of a variety of ... , dermaka cream is very effective for bruising and causes a rapid resolution of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
Breaking Medicine Technology: